Laurent Vernhet

2.6k total citations
72 papers, 2.0k citations indexed

About

Laurent Vernhet is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Laurent Vernhet has authored 72 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 19 papers in Pulmonary and Respiratory Medicine and 13 papers in Oncology. Recurrent topics in Laurent Vernhet's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (19 papers), Drug Transport and Resistance Mechanisms (12 papers) and Retinoids in leukemia and cellular processes (11 papers). Laurent Vernhet is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (19 papers), Drug Transport and Resistance Mechanisms (12 papers) and Retinoids in leukemia and cellular processes (11 papers). Laurent Vernhet collaborates with scholars based in France, Germany and Spain. Laurent Vernhet's co-authors include Olivier Fardel, Claudie Morzadec, Anthony Lemarié, Nathalie Allain, S. Jouneau, Emilie Bourdonnay, Valérie Lecureur, Dominique Lagadic‐Gossmann, Arnaud Courtois and Lydie Sparfel and has published in prestigious journals such as The Journal of Immunology, Cancer Research and Oncogene.

In The Last Decade

Laurent Vernhet

70 papers receiving 2.0k citations

Peers

Countries citing papers authored by Laurent Vernhet

Since Specialization

Citations

This map shows the geographic impact of Laurent Vernhet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laurent Vernhet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laurent Vernhet more than expected).

Fields of papers citing papers by Laurent Vernhet

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laurent Vernhet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laurent Vernhet. The network helps show where Laurent Vernhet may publish in the future.

Co-authorship network of co-authors of Laurent Vernhet

This figure shows the co-authorship network connecting the top 25 collaborators of Laurent Vernhet. A scholar is included among the top collaborators of Laurent Vernhet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laurent Vernhet. Laurent Vernhet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Anti-fibrotic effects of nintedanib on lung fibroblasts derived from patients with Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs) 2023 ·Pulmonary Pharmacology & Therapeutics ·Audrey Joannes, (unknown), Claudie Morzadec, (unknown), (unknown), (unknown), (unknown), Stéphanie Guillot, (unknown), (unknown), Madeleine Jaillet, Bruno Crestani, Lutz Wollin, S. Jouneau, Laurent Vernhet	6
2	Effects of Ruxolitinib on fibrosis in preclinical models of systemic sclerosis 2023 ·International Immunopharmacology ·(unknown), M Lelong, Audrey Joannes, (unknown), S. Jouneau, Laurent Vernhet, Alain Lescoat, Valérie Lecureur	16
3	Malnutrition and decreased food intake at diagnosis are associated with hospitalization and mortality of idiopathic pulmonary fibrosis patients 2022 ·Clinical Nutrition ·S. Jouneau, Chloé Rousseau, Mathieu Léderlin, Alain Lescoat, M. Kerjouan, Pierre Chauvin, David Luque-Paz, Stéphanie Guillot, Emmanuel Oger, Laurent Vernhet, Ronan Thibault	26
4	Post hoc Analysis of Clinical Outcomes in Placebo- and Pirfenidone-Treated Patients with IPF Stratified by BMI and Weight Loss 2021 ·Respiration ·S. Jouneau, Bruno Crestani, Ronan Thibault, Mathieu Léderlin, Laurent Vernhet, Ming Yang, Elizabeth Morgenthien, Klaus-Uwe Kirchgaessler, Vincent Cottin	16
5	Usefulness of Body Composition CT Analysis in Patients with Idiopathic Pulmonary Fibrosis: A Pilot Study 2021 ·Academic Radiology ·(unknown), (unknown), S. Jouneau, Chloé Rousseau, (unknown), (unknown), Alain Lescoat, David Luque-Paz, (unknown), Laurent Vernhet, Ronan Thibault, Mathieu Léderlin	12
6	What are the best indicators to assess malnutrition in idiopathic pulmonary fibrosis patients? A cross-sectional study in a referral center 2018 ·Nutrition ·S. Jouneau, M. Kerjouan, Chloé Rousseau, Mathieu Léderlin, (unknown), B. de Latour, Stéphanie Guillot, Laurent Vernhet, B. Desrues, Ronan Thibault	38
7	Factors determining the exposure of dairy farmers to thoracic organic dust 2018 ·Environmental Research ·Hugo Pfister, Laurent Madec, Pierre Le Cann, Nathalie Costet, (unknown), S. Jouneau, Laurent Vernhet	17
8	Nrf2 expression and activity in human T lymphocytes: stimulation by T cell receptor activation and priming by inorganic arsenic and tert-butylhydroquinone 2014 ·Free Radical Biology and Medicine ·Claudie Morzadec, (unknown), Lydie Sparfel, Saadia Kerdine‐Römer, Olivier Fardel, Laurent Vernhet	58
9	Inorganic arsenic alters expression of immune and stress response genes in activated primary human T lymphocytes 2011 ·Molecular Immunology ·Corinne Martin‐Chouly, Claudie Morzadec, Mélodie Bonvalet, Marie‐Dominique Galibert, Olivier Fardel, Laurent Vernhet	41
10	Inorganic Arsenic Activates Reduced NADPH Oxidase in Human Primary Macrophages through a Rho Kinase/p38 Kinase Pathway 2008 ·The Journal of Immunology ·Anthony Lemarié, Emilie Bourdonnay, Claudie Morzadec, Olivier Fardel, Laurent Vernhet	54
11	Inorganic arsenic induces necrosis of human CD34‐positive haematopoietic stem cells 2008 ·Environmental Toxicology ·Laurent Vernhet, Claudie Morzadec, Julien van Grevenynghe, Benoît Bareau, (unknown), Thierry Fest, Olivier Fardel	10
12	Cisplatin-Induced Apoptosis Involves Membrane Fluidification via Inhibition of NHE1 in Human Colon Cancer Cells 2007 ·Cancer Research ·Amélie Rébillard, Xavier Tekpli, Olivier Meurette, Odile Sergent, (unknown), Laurent Vernhet, Morgane Gorria, Martine Chevanne, Markus Christmann, Bernd Kaina, Laurent Counillon, Erich Gulbins, Dominique Lagadic‐Gossmann, Marie‐Thérèse Dimanche‐Boitrel	131
13	Human Macrophages Constitute Targets for Immunotoxic Inorganic Arsenic 2006 ·The Journal of Immunology ·Anthony Lemarié, Claudie Morzadec, Emilie Bourdonnay, Olivier Fardel, Laurent Vernhet	110
14	Arsenic Trioxide Induces Apoptosis of Human Monocytes during Macrophagic Differentiation through Nuclear Factor-κB-Related Survival Pathway Down-Regulation 2005 ·Journal of Pharmacology and Experimental Therapeutics ·Anthony Lemarié, Claudie Morzadec, Delphine Mérino, Olivier Micheau, Olivier Fardel, Laurent Vernhet	68
15	Blockage of Multidrug Resistance-Associated Proteins Potentiates the Inhibitory Effects of Arsenic Trioxide on CYP1A1 Induction by Polycyclic Aromatic Hydrocarbons 2003 ·Journal of Pharmacology and Experimental Therapeutics ·Laurent Vernhet, Nathalie Allain, Marc Le Vée, Fabrice Morel, André Guillouzo, Olivier Fardel	32
16	Resistance of human multidrug resistance-associated protein 1-overexpressing lung tumor cells to the anticancer drug arsenic trioxide11Abbreviations: MRP1, multidrug resistance-associated protein 1; As2O3, arsenic trioxide; MTT, 3-(4-5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; and BSO, buthionine sulfoximine. 2001 ·Biochemical Pharmacology ·Laurent Vernhet, Nathalie Allain, (unknown), Jean-Pierre Anger, (unknown), Olivier Fardel	43
17	Inhibition of multidrug resistance-associated protein (MRP) activity by rifampicin in human multidrug-resistant lung tumor cells 1999 ·Cancer Letters ·Arnaud Courtois, Léa Payen, Laurent Vernhet, Elisabeth G.E. de Vries, André Guillouzo, Olivier Fardel	24
18	Use of the anionic dye carboxy-2',7'-dichlorofluorescein for sensitive flow cytometric detection of multidrug resistance-associated protein activity. 1999 ·International Journal of Oncology ·Béatrice Laupèze, Laurence Amiot, Arnaud Courtois, Laurent Vernhet, Bernard Drénou, R Fauchet, Olivier Fardel	31
19	Synthesis and Potent Tumour Necrosis Factor-α Production Inhibitory Activity of N-Pyridinylphthalimides and Derivatives 1998 ·Pharmacy and Pharmacology Communications ·(unknown), J.-M. Robert, (unknown), Guillaume Le Baut, Christine Bobin‐Dubigeon, Laurent Vernhet, François Lang, Jean‐Yves Petit	1
20	Modulation of Platelet‐Activating‐Factor Production by Incorporation of Naturally Occurring 1‐O‐Alkylglycerols in Phospholipids of Human Leukemic Monocyte‐Like THP‐1 Cells 1997 ·European Journal of Biochemistry ·Aziz Hichami, (unknown), Véronique Leblais, Laurent Vernhet, François Le Goffic, Ewa Ninio, Alain Legrand	23

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact